ATE337313T1 - 5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz - Google Patents

5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz

Info

Publication number
ATE337313T1
ATE337313T1 AT01272109T AT01272109T ATE337313T1 AT E337313 T1 ATE337313 T1 AT E337313T1 AT 01272109 T AT01272109 T AT 01272109T AT 01272109 T AT01272109 T AT 01272109T AT E337313 T1 ATE337313 T1 AT E337313T1
Authority
AT
Austria
Prior art keywords
thiazolidine
pyridyl
ethoxy
benzyl
amino
Prior art date
Application number
AT01272109T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Deirdre O'keeffe
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031521A external-priority patent/GB0031521D0/en
Priority claimed from GB0031524A external-priority patent/GB0031524D0/en
Priority claimed from GB0031526A external-priority patent/GB0031526D0/en
Priority claimed from GB0031528A external-priority patent/GB0031528D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE337313T1 publication Critical patent/ATE337313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01272109T 2000-12-22 2001-12-21 5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz ATE337313T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0031521A GB0031521D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031524A GB0031524D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031526A GB0031526D0 (en) 2000-12-22 2000-12-22 Novel pharmaceuticals
GB0031528A GB0031528D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ATE337313T1 true ATE337313T1 (de) 2006-09-15

Family

ID=27447913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01272109T ATE337313T1 (de) 2000-12-22 2001-12-21 5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz

Country Status (12)

Country Link
US (2) US20040082620A1 (de)
EP (1) EP1349855B1 (de)
JP (1) JP2004520326A (de)
KR (1) KR100840846B1 (de)
CN (1) CN1310912C (de)
AT (1) ATE337313T1 (de)
CY (1) CY1106226T1 (de)
DE (1) DE60122580T2 (de)
DK (1) DK1349855T3 (de)
ES (1) ES2270955T3 (de)
PT (1) PT1349855E (de)
WO (1) WO2002051839A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
EA018427B1 (ru) * 2003-12-16 2013-07-30 Нектар Терапьютикс Химически модифицированный налоксон
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP2062880A1 (de) 2007-11-22 2009-05-27 Bayer Schering Pharma Aktiengesellschaft 5-[(3,3,3-Trifluor-2-hydroxy-1-arylpropyl)amino]-1H-chinolin-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als entzündungshemmende Wirkstoffe
PT2621496E (pt) 2010-09-30 2016-02-01 Astrazeneca Ab Conjugado naloxol-peg cristalino

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
DE60122580D1 (de) 2006-10-05
ES2270955T3 (es) 2007-04-16
DK1349855T3 (da) 2006-12-27
PT1349855E (pt) 2006-12-29
KR100840846B1 (ko) 2008-06-23
CN1491224A (zh) 2004-04-21
EP1349855A1 (de) 2003-10-08
KR20030064855A (ko) 2003-08-02
DE60122580T2 (de) 2007-08-30
WO2002051839A1 (en) 2002-07-04
US20040082620A1 (en) 2004-04-29
JP2004520326A (ja) 2004-07-08
US20060040993A1 (en) 2006-02-23
US7291740B2 (en) 2007-11-06
CY1106226T1 (el) 2011-06-08
EP1349855B1 (de) 2006-08-23
CN1310912C (zh) 2007-04-18

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
ATE337313T1 (de) 5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
GB0021784D0 (en) Novel pharmaceutical
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
CY1106397T1 (el) Βενζολοσουλφονικη 5-(4-(2-(ν-μεθυλο-ν-(2-πυριδιλ)αμινο)αιθοξυ)βενζυλο) θειαζολιδινο-2,4-διονη ˙ διepγασια παρασκευης αυτης ˙ πολυμορφες ι,ιι και ιιι αυτης ˙ και χρηση αυτης ως φαρμακευτικο δραστικο συστατικο
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona
ECSP003434A (es) Nuevos compuestos
HK1068883A (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349855

Country of ref document: EP

REN Ceased due to non-payment of the annual fee